Harvard Bioscience, Inc. (HBIO)
NASDAQ · Healthcare
Harvard Bioscience, Inc. Operating Income 2009–2025
Harvard Bioscience, Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Harvard Bioscience, Inc. operating income for the quarter ending March 31, 2026 was -1.2 M, a 97.64% decrease year-over-year.
- Harvard Bioscience, Inc. operating income for the twelve months ending March 31, 2026 was -51.5 M, a 619.27% increase year-over-year.
- Harvard Bioscience, Inc. annual operating income for 2025 was -48.6 M, a 682.16% increase from 2024.
- Harvard Bioscience, Inc. annual operating income for 2024 was -6.2 M, a 427.93% decrease from 2023.
- Harvard Bioscience, Inc. annual operating income for 2023 was 1.9 M, a 127.32% decrease from 2022.
- Harvard Bioscience, Inc. annual operating income for 2022 was -6.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Harvard Bioscience, Inc. Operating Income — FAQ
Harvard Bioscience, Inc. (HBIO) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Harvard Bioscience, Inc.'s operating income?
Harvard Bioscience, Inc. (HBIO) reported operating income of -$49M for fiscal 2025.
Where can I see HBIO's operating income history?
The chart and table above show Harvard Bioscience, Inc.'s operating income by year and by quarter, including the growth rate.